News

Novo Nordisk has said it is discontinuing selling its popular, best-selling insulin brand in India and will instead promote ...
It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...
The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...
T he US Food and Drug Administration (FDA) and pharmaceutical company Novo Nordisk are now in an attempt to making more ...
Indian diabetic population on Human Mixtard concerned on changes in insulin therapy: Nandita Vijayasimha, Bengaluru Thursday, April 24, 2025, 08:00 Hrs [IST] India’s diabetic po ...
Novo Nordisk A/S (NYSE:NVO) said it had become aware of several hundred units of Ozempic (semaglutide) injection 1 mg distributed outside the Novo Nordisk authorized supply chain in the U.S. The ...
The FDA and the maker of the popular diabetes and weight loss drug Ozempic are warning people not to use ...
After selling off a portion of its diabetes care business last year, Ypsomed is now fully exiting the diabetes care business ...
The drug company Eli Lilly is suing four telehealth companies for allegedly selling copies made by compounding pharmacies of ...
Individuals in possession of a counterfeit Ozempic product are encouraged to report it to Novo Nordisk customer care at 1-800-727-6500 during business hours. Additionally, any adverse events should be ...
which has been confirmed as ingenuine by Ozempic manufacturer Novo Nordisk. Any pens marked with the batch number should be taken to a local pharmacy for safe disposal, the TGA said. Counterfeit ...